CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+9.06%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.6B
AUM Growth
+$2.59B
(+22%)
Cap. Flow
+$828M
Cap. Flow
% of AUM
5.67%
Top 10 Holdings %
Top 10 Hldgs %
21.92%
Holding
968
New
130
Increased
364
Reduced
334
Closed
74
Top Buys
| 1 |
Microsoft
MSFT
|
$144M |
| 2 |
Royal Bank of Canada
RY
|
$123M |
| 3 |
Agilent Technologies
A
|
$78.5M |
| 4 |
UnitedHealth
UNH
|
$71.8M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$70.8M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$92.6M |
| 2 |
Amgen
AMGN
|
$87.9M |
| 3 |
Allstate
ALL
|
$52.7M |
| 4 |
PayPal
PYPL
|
$47.9M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
$47.4M |
Sector Composition
| 1 | Healthcare | 33.43% |
| 2 | Technology | 23.21% |
| 3 | Consumer Discretionary | 9.15% |
| 4 | Financials | 8.64% |
| 5 | Communication Services | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Intuit
INTU
$188B
| $15.1M | 0.1% |
30,881
-47,597
| -61% | -$23.3M |
|
227
Union Pacific
UNP
$131B
| $15.1M | 0.1% |
68,730
-211,381
| -75% | -$46.5M |
|
228
Bloom Energy
BE
$13.4B
| $15.1M | 0.1% |
562,311
+129,252
| +30% | +$3.47M |
|
229
argenx
ARGX
$45.9B
| $14.9M | 0.1% |
49,526
+10,753
| +28% | +$3.24M |
|
|
ATH
230
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $14.8M | 0.1% |
+219,060
| New | +$14.8M |
|
231
CytomX Therapeutics
CTMX
$376M
| $14.7M | 0.1% |
2,328,353
+2,328,207
| +1,594,662% | +$14.7M |
|
|
PRAH
232
DELISTED
PRA Health Sciences, Inc.
PRAH
| $14.5M | 0.1% |
+87,515
| New | +$14.5M |
|
233
Insmed
INSM
$30.7B
| $14.4M | 0.1% |
505,241
+222,340
| +79% | +$6.33M |
|
234
KLA
KLAC
$119B
| $14.2M | 0.1% |
43,674
-2,495
| -5% | -$809K |
|
235
KeyCorp
KEY
$20.8B
| $14M | 0.1% |
680,162
+245,884
| +57% | +$5.08M |
|
236
AT&T
T
$212B
| $13.9M | 0.1% |
640,780
-841,651
| -57% | -$18.3M |
|
237
TG Therapeutics
TGTX
$5.11B
| $13.7M | 0.09% |
353,983
-656,244
| -65% | -$25.5M |
|
238
Ecolab
ECL
$77.6B
| $13.7M | 0.09% |
66,509
-77,360
| -54% | -$15.9M |
|
239
Zscaler
ZS
$42.7B
| $13.6M | 0.09% |
62,914
+56,445
| +873% | +$12.2M |
|
240
Oracle
ORCL
$654B
| $13.5M | 0.09% |
173,069
-115,108
| -40% | -$8.96M |
|
241
Nurix Therapeutics
NRIX
$758M
| $13.5M | 0.09% |
507,303
+507,290
| +3,902,231% | +$13.5M |
|
242
Celldex Therapeutics
CLDX
$1.52B
| $13.4M | 0.09% |
399,685
+55,546
| +16% | +$1.86M |
|
243
Xenon Pharmaceuticals
XENE
$3.02B
| $13.3M | 0.09% |
+715,722
| New | +$13.3M |
|
244
Zai Lab
ZLAB
$3.42B
| $13.2M | 0.09% |
65,648
+65,643
| +1,312,860% | +$13.2M |
|
|
ITCI
245
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $13M | 0.09% |
319,487
-136,535
| -30% | -$5.57M |
|
246
General Mills
GIS
$27B
| $13M | 0.09% |
213,039
-71,394
| -25% | -$4.35M |
|
|
ITOS
247
DELISTED
iTeos Therapeutics
ITOS
| $13M | 0.09% |
504,890
+504,872
| +2,804,844% | +$13M |
|
248
Caterpillar
CAT
$198B
| $12.9M | 0.09% |
59,327
-142
| -0.2% | -$30.9K |
|
|
CHNG
249
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $12.8M | 0.09% |
+553,958
| New | +$12.8M |
|
|
KSU
250
DELISTED
Kansas City Southern
KSU
| $12.7M | 0.09% |
44,985
+535
| +1% | +$152K |
|